J22352 T11701
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
J22352 promotes HDAC6 degradation and induces anticancer effects by inhibiting autophagy and eliciting the antitumor immune response in glioblastoma cancers, and leading to the restoration of host antitumor activity by reducing the immunosuppressive activ
CAS nr:
2252395-44-9
Purity:
98%
Molecular Weight:
415,44
SMILES:
O=C(C1=CC=CC=C1N2CC3=CC=C(C(NO)=O)C=C3)N(CCC4=CC=CC=C4)C2=O
Formula:
C24H21N3O4
Pathway:
Proteases/Proteasome,Apoptosis
Target:
Caspase,Caspase
